However, to our knowledge, only a limited number of studies have been conducted on the association analysis of these particular polymorphisms of ERCC5 (rs751402, rs17655, rs2094258, and rs873601) in BC patients and their response to chemotherapy. Here, ERCC5 is linked to breast cancer.